Oncology Drugs Advertised on TV
14 prescription oncology medications seen in TV advertising, ranked by estimated annual ad spend.
pembrolizumab · Multiple cancers
abemaciclib · HR+/HER2- breast cancer
palbociclib · HR+/HER2- breast cancer
ribociclib · HR-positive, HER2-negative breast cancer
pembrolizumab · Multiple cancers
olaparib · Ovarian, breast, prostate, and pancreatic cancers
osimertinib · EGFR-positive non-small cell lung cancer
acalabrutinib · Chronic lymphocytic leukemia and mantle cell lymphoma
ibrutinib · Chronic lymphocytic leukemia and other blood cancers
apalutamide · Prostate cancer
Popular comparisons
Frequently asked questions
What oncology drugs are advertised on TV?
Keytruda, Opdivo, Xtandi, Verzenio, Ibrance and 9 more are among the oncology medications currently advertised on television. TVPills tracks 14 of them.
Which oncology drug spends the most on TV advertising?
Keytruda (pembrolizumab) leads with an estimated $260M in annual TV ad spend.
Which oncology medication is right for me?
TVPills is an informational reference, not medical advice. Only a licensed healthcare provider can recommend the right oncology treatment for your situation.